The decision in the Bayer Corp. contempt case has important implications for the dietary supplement industry, say attorneys Steven Shapiro and Marc Ullman in this guest article:
Former FDA official Dr Joshua Sharfstein, MD, has proposed a new paradigm for the regulation of dietary supplements. The underlying shift would be a move from an attitude of “benefit versus risk” to one of “access with safety.”
Extracting omega-3 from novel algae sources is the mission of a European Union-funded project with multiple partners including the famed nutrition research arm at Wageningen University in the Netherlands.
There’s a new player in the GMP audit sector, with the United States Pharmacopeial Convention (USP) expanding its verification services to include a new GMP audit program for dietary supplement and dietary ingredient manufacturers.
The Board of the Council for Responsible Nutrition has adopted the proposal to move forward with a registry of dietary supplements, which could be a relatively quick process if an existing database can be ‘massaged’ to fit the criteria.
If you didn't make it to Chicago last week for the inaugural Food Vision USA event, you missed a truly awesome ensemble of industry experts covering everything from our nutritional needs on a manned mission to Mars to the challenges facing small...
